Irina Staatz, Phd
Bussiness And Management
Blink Biomedical
United States of America
Biography
Irina has successfully negotiated a broad variety of agreements. Prior to her own business she held various senior management positions in product development, international marketing and business development at Hermal (Merck KGaA), Boots Healthcare International and Knoll (later Abbott) and served as CEO of the biotechnology companies Scil Technology as well as U3 Pharma which she sold to Daiichi Sankyo. Irina serves as Vice Chairman of the Board of the public French biotech company Innate Pharma and Chairman of BliNK Therapeutics, UK.
Research Interest
Business
